These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8320424)

  • 21. Effects of KCA-098 on bone metabolism: comparison with those of ipriflavone.
    Tsutsumi N; Kawashima K; Nagata H; Tsuyuki J; Itoh F; Arai N; Kojima M; Ujiie A; Endo H
    Jpn J Pharmacol; 1994 Aug; 65(4):343-9. PubMed ID: 7990272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ipriflavone inhibits bone resorption in intact and ovariectomized rats.
    Cecchini MG; Fleisch H; Mühibauer RC
    Calcif Tissue Int; 1997; 61 Suppl 1():S9-11. PubMed ID: 9263609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ipriflavone on postmenopausal syndrome and osteoporosis.
    Zhang X; Li SW; Wu JF; Dong CL; Zheng CX; Zhang YP; Du J
    Gynecol Endocrinol; 2010 Feb; 26(2):76-80. PubMed ID: 19672742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ipriflavone modulates IGF-I but is unable to restore bone in rats.
    Deyhim F; Smith BJ; Soung DY; Juma S; Devareddy L; Arjmandi BH
    Phytother Res; 2005 Feb; 19(2):116-20. PubMed ID: 15852487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone.
    Agnusdei D; Gennari C; Bufalino L
    Osteoporos Int; 1995; 5(6):462-6. PubMed ID: 8695969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis.
    Agnusdei D; Adami S; Cervetti R; Crepaldi G; Di Munno O; Fantasia L; Isaia GC; Letizia G; Ortolani S; Passeri M
    Bone Miner; 1992 Oct; 19 Suppl 1():S43-8. PubMed ID: 1422320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of soy isoflavone and/or estrogen treatments on bone metabolism in ovariectomized rats.
    Kim MS; Lee YS
    J Med Food; 2005; 8(4):439-45. PubMed ID: 16379553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of an ipriflavone-containing supplement on urinary N-linked telopeptide levels in postmenopausal women.
    Halpner AD; Kellermann G; Ahlgrimm MJ; Arndt CL; Shaikh NA; Hargrave JJ; Tallas PG
    J Womens Health Gend Based Med; 2000 Nov; 9(9):995-8. PubMed ID: 11103099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ipriflavone improves bone density and biomechanical properties of adult male rat bones.
    Civitelli R; Abbasi-Jarhomi SH; Halstead LR; Dimarogonas A
    Calcif Tissue Int; 1995 Mar; 56(3):215-9. PubMed ID: 7750027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ipriflavone: an important bone-building isoflavone.
    Head KA
    Altern Med Rev; 1999 Feb; 4(1):10-22. PubMed ID: 9988779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of ipriflavone and 1 alpha vitamin D therapy for the cessation of vertebral bone loss.
    Ushiroyama T; Okamura S; Ikeda A; Ueki M
    Int J Gynaecol Obstet; 1995 Mar; 48(3):283-8. PubMed ID: 7781871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ipriflavone: background.
    Gennari C
    Calcif Tissue Int; 1997; 61 Suppl 1():S3-4. PubMed ID: 9263607
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
    J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ipriflavone on caged layer bone metabolism in vitro and in vivo.
    Yao J; Zhang J; Hou JF
    Poult Sci; 2007 Mar; 86(3):503-7. PubMed ID: 17297162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ipriflavone on bone mass in elderly osteoporotic women.
    Passeri M; Biondi M; Costi D; Bufalino L; Castiglione GN; Di Peppe C; Abate G
    Bone Miner; 1992 Oct; 19 Suppl 1():S57-62. PubMed ID: 1422322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis.
    Agnusdei D; Zacchei F; Bigazzi S; Cepollaro C; Nardi P; Montagnani M; Gennari C
    Drugs Exp Clin Res; 1989; 15(2):97-104. PubMed ID: 2661184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ipriflavone promotes osteogenesis of MSCs derived from osteoporotic rats.
    Gao AG; Zhou YC; Hu ZJ; Lu BB
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4669-4676. PubMed ID: 30058710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ipriflavone].
    Kitatani K; Morii H
    Nihon Rinsho; 1998 Jun; 56(6):1537-43. PubMed ID: 9648478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A calcium-collagen chelate dietary supplement attenuates bone loss in postmenopausal women with osteopenia: a randomized controlled trial.
    Elam ML; Johnson SA; Hooshmand S; Feresin RG; Payton ME; Gu J; Arjmandi BH
    J Med Food; 2015 Mar; 18(3):324-31. PubMed ID: 25314004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The future of ipriflavone in the management of osteoporotic syndromes.
    Avioli LV
    Calcif Tissue Int; 1997; 61 Suppl 1():S33-5. PubMed ID: 9263615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.